David Bouchey
Stock Analyst at Aegis Capital
(n/a)
# 4,475
Out of 4,479 analysts
6
Total ratings
n/a
Success rate
-61.2%
Average return
Main Sectors:
5 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SBFM Sunshine Biopharma | Initiates: Buy | $260 | $0.32 | +81,048.56% | 1 | Aug 7, 2023 | |
| STSS Sharps Technology | Initiates: Buy | $16 | $0.24 | +6,622.69% | 1 | May 9, 2023 | |
| ATXI Avenue Therapeutics | Initiates: Buy | $2,400 | $3.41 | +70,281.23% | 1 | Apr 3, 2023 | |
| IINN Inspira Technologies Oxy B.H.N. | Maintains: Buy | $10 → $13 | $1.39 | +835.25% | 1 | Jan 25, 2023 | |
| RMTI Rockwell Medical | Downgrades: Outperform | $121 | $1.69 | +7,059.76% | 2 | Oct 19, 2018 |
Sunshine Biopharma
Aug 7, 2023
Initiates: Buy
Price Target: $260
Current: $0.32
Upside: +81,048.56%
Sharps Technology
May 9, 2023
Initiates: Buy
Price Target: $16
Current: $0.24
Upside: +6,622.69%
Avenue Therapeutics
Apr 3, 2023
Initiates: Buy
Price Target: $2,400
Current: $3.41
Upside: +70,281.23%
Inspira Technologies Oxy B.H.N.
Jan 25, 2023
Maintains: Buy
Price Target: $10 → $13
Current: $1.39
Upside: +835.25%
Rockwell Medical
Oct 19, 2018
Downgrades: Outperform
Price Target: $121
Current: $1.69
Upside: +7,059.76%